Retrieve available abstracts of 119 articles: HTML format
Single Articles
May 2025
CHO WK, Park W, Kim SW, Lee KK, et al Postoperative hypofractionated intensity-modulated radiation therapy in cervical
cancer: prospective phase 2 trial (POHIM_RT study).
Gynecol Oncol. 2025;198:84-89. PubMedAbstract available
ACOSTA U, Bebia V, Torne A, Carreras-Dieguez N, et al Topographic mapping of pelvic and aortic lymph node metastases in stage IIIC1r
locally advanced cervical cancer: A retrospective study by the Spain-GOG group.
Gynecol Oncol. 2025;198:49-54. PubMedAbstract available
LEE JY, Boonyapipat S, Yuan G, Kim HS, et al AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab
plus tislelizumab and tislelizumab alone in patients with previously treated
recurrent or metastatic cervical cancer.
Gynecol Oncol. 2025;198:25-32. PubMedAbstract available
GU J, Zheng W, Li F, Luo C, et al Redefining stage IVB cervical cancer: The unique prognosis of distant lymph node
metastasis which is comparable to stage IIIC.
Gynecol Oncol. 2025;198:17-24. PubMedAbstract available
April 2025
BAE J, Kim U, Paik ES, Lim MC, et al Oncologic outcomes of minimally invasive surgery vs. abdominal hysterectomy in
patients with low-risk, early-stage cervical cancer: A retrospective analysis of
KGOG 1028 data based on SHAPE trial eligibility criteria.
Gynecol Oncol. 2025;197:91-95. PubMedAbstract available
FRIEDMAN EL, Guo XM, Furey KB, Lee AJ, et al Temporal trends of sentinel lymph node biopsy without lymphadenectomy at cervical
cancer surgery.
Gynecol Oncol. 2025;196:182-191. PubMedAbstract available
BORCINOVA M, Kohler C, Nemejcova K, Zapardiel I, et al Preoperative tumour size assessment in patients with early-stage cervical cancer:
Final results of the SENTIX study.
Gynecol Oncol. 2025;196:160-167. PubMedAbstract available
WOLF B, Trantaki DS, Horn LC, Aktas B, et al Preoperative conization in cervical cancer patients undergoing open abdominal
radical hysterectomy: Results from a propensity-score matched study.
Gynecol Oncol. 2025;196:69-77. PubMedAbstract available
LEATH CA 3RD, Deng W, Mell LK, Richardson DL, et al Incorporation of triapine (T) to cisplatin chemoradiation (CRT) for locally
advanced cervical and vaginal cancer: Results from NRG-GY006, a phase III
randomized trial.
Gynecol Oncol. 2025;195:122-133. PubMedAbstract available
March 2025
LORUSSO D, Oaknin A, Borges GS, Damian F, et al Cemiplimab plus peltopepimut-S vaccine in recurrent cervical cancer: A phase 2
clinical trial.
Gynecol Oncol. 2025;196:28-35. PubMedAbstract available
KIM J, Jang J, Lim MC, Kim MH, et al Which factors predict the effectiveness of adjuvant treatment in patients with
non-high-risk early-stage cervical cancer? Ancillary analysis of KGOG-1028.
Gynecol Oncol. 2025;196:10-15. PubMedAbstract available
DE BONDT D, Naslazi E, Jansen E, Kupets R, et al Validating the predicted impact of HPV vaccination on HPV prevalence, cervical
lesions, and cervical cancer: A systematic review of population level data and
modelling studies.
Gynecol Oncol. 2025;195:134-143. PubMedAbstract available
CARTER J, Huang HQ, Monk BJ, Kim YB, et al Evaluation of physical function and quality of life before and after nonradical
surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278).
Gynecol Oncol. 2025;195:50-58. PubMedAbstract available
COVENS A, Huang HQ, Monk BJ, Kim YB, et al Evaluation of efficacy and fertility after nonradical surgical therapy (extra
fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1,
IA2, and IB1 cervical cancer (GOG-0278).
Gynecol Oncol. 2025;195:59-65. PubMedAbstract available
VELASQUEZ J, Mohammed-Norgan M, Scheiber A, Chalif J, et al Cross-language insights: Comparing Spanish and English-language cervical cancer
content on TikTok.
Gynecol Oncol. 2025;194:131-136. PubMedAbstract available
February 2025
WALKER AR, Leite S, Chen YS, Huepenbecker SP, et al Sentinel lymph node biopsy at the time of hysterectomy for early-stage cervical
cancer: A cost-effectiveness analysis.
Gynecol Oncol. 2025;195:1-5. PubMedAbstract available
MACDUFFIE E, Kernell C, George J, Bvochora-Nsingo M, et al Efficacy of induction chemotherapy during the COVID-19 pandemic for treatment of
locally advanced cervical cancer in Botswana.
Gynecol Oncol. 2025;194:91-97. PubMedAbstract available
January 2025
KIM YJ, Lee J, Park S, Kim YM, et al The value of magnetic resonance imaging in predicting vesicovaginal fistula in
cervical cancer with bladder invasion treated with definitive chemoradiotherapy.
Gynecol Oncol. 2025;193:136-140. PubMedAbstract available
SCHAAFSMA M, Schuurman TN, Siebers AG, Bekkers RLM, et al Cost-effectiveness of an additional hysterectomy after initially conservative
treatment for cervical adenocarcinoma in situ.
Gynecol Oncol. 2025;193:113-118. PubMedAbstract available
LEIJTENS L, Piek J, Verrijssen AS, Rijkaart D, et al Thromboprophylaxis in patients with locally advanced cervical cancer treated with
chemoradiation and brachytherapy.
Gynecol Oncol. 2025;193:41-48. PubMedAbstract available
December 2024
NGUYEN T, Yi Y, Morron S, Brittain D, et al Living in a food desert in Louisiana and its effects on gynecologic cancer
outcomes.
Gynecol Oncol. 2024;192:137-144. PubMedAbstract available
WONG TY, Adzibolosu NK, Mattei LH, Speak AC, et al Disparities in contemporary human papilloma virus vaccination uptake among adult
women living in the United States: An All of Us Research Program study.
Gynecol Oncol. 2024;191:100-105. PubMedAbstract available
November 2024
DE JAEGHERE EA, Hamerlinck H, Tuyaerts S, Lippens L, et al Associations of the gut microbiome with outcomes in cervical and endometrial
cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO
trial.
Gynecol Oncol. 2024;191:275-286. PubMedAbstract available
JAIN D, Zaeim F, Wahidi M, Smith WJ, et al Cervical squamous cell carcinoma outcomes across continents: A retrospective
study.
Gynecol Oncol. 2024;190:272-282. PubMedAbstract available
CHOI YK, Lee JH, Kim YS, Wee CW, et al Mid-treatment MRI-based tumor response assessment for tumor recurrence and
patient survival in locally advanced adenocarcinoma of the cervix: A
retrospective multicenter study of KROG 23-03.
Gynecol Oncol. 2024;190:222-229. PubMedAbstract available
NONZEE NJ, Thiel de Bocanegra H, Navarro S, Bastani R, et al Impact of management guidelines for abnormal cervical cytology on colposcopy
procedure rates among young women.
Gynecol Oncol. 2024;190:160-166. PubMedAbstract available
October 2024
HUNSBERGER KS, Tewari KS, Monk BJ, Chase DM, et al Standard of care treatment for stage IVB cervical cancer: A systematic review and
meta-analysis.
Gynecol Oncol. 2024;191:259-264. PubMedAbstract available
LI G, Li X, Yin R, Feng M, et al Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with
PD-L1 positive recurrent/metastatic cervical cancer.
Gynecol Oncol. 2024;191:165-171. PubMedAbstract available
ELAYAPILLAI SP, Dogra S, Lausen J, Parker M, et al ATR inhibition increases reliance on PARP-mediated DNA repair revealing an
improved therapeutic strategy for cervical cancer.
Gynecol Oncol. 2024;191:182-193. PubMedAbstract available
NG ZY, Manchanda R, Lopez A, Obermair A, et al The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study.
Gynecol Oncol. 2024;191:95-99. PubMedAbstract available
September 2024
LINDQUIST S, Kjaer SK, Frederiksen K, Ornskov D, et al Comparative analysis of HPV testing versus cytology in Danish cervical cancer
screening: Insights from a large-scale implementation study.
Gynecol Oncol. 2024;191:45-55. PubMedAbstract available
YANG X, Li C, Li Z, Du D, et al The clinical value of ultrasound-guided sacral anesthesia in Intracavitary and/or
interstitial brachytherapy for cervical Cancer.
Gynecol Oncol. 2024;191:31-36. PubMedAbstract available
FULLERTON R, Martell K, Khanolkar R, Phan T, et al Impact of immune, inflammatory and nutritional indices on outcome in patients
with locally advanced cervical cancer treated with definitive
(chemo)radiotherapy.
Gynecol Oncol. 2024;190:291-297. PubMedAbstract available
NGUYEN L, Chung TH, Le YL, Reygaerts H, et al Hispanic individuals' cervical cancer screening disparities amidst the COVID-19
pandemic.
Gynecol Oncol. 2024;190:243-249. PubMedAbstract available
MONK BJ, Tewari KS, Randall LM, Pothuri B, et al Immunotherapy in locally advanced cervix cancer: A critical appraisal of the FDA
indication based on ENGOT-CX11/GOG-3047/KEYNOTE-A18.
Gynecol Oncol. 2024;188:81-82. PubMed
August 2024
LIM H, Kim SI, Kim MK, Yoon SH, et al Initial sarcopenia and body composition changes as prognostic factors in cervical
cancer patients treated with concurrent chemoradiation: An artificial
intelligence-based volumetric study.
Gynecol Oncol. 2024;190:200-208. PubMedAbstract available
MILLER EA, Chowdhary B, Chapman-Davis E Beyond the decision: Reproductive justice and cervical cancer care in a
post-Dobbs era.
Gynecol Oncol. 2024;190:186-188. PubMedAbstract available
FRICOVA L, Kommoss S, Scambia G, Ferron G, et al Reproductive outcomes after fertility-sparing surgery for cervical cancer -
results of the multicenter FERTISS study.
Gynecol Oncol. 2024;190:179-185. PubMedAbstract available
CHUK E, Conway JL, Hanuschak J, Han K, et al Patient-reported sexual health outcomes of cervical cancer patients treated with
definitive chemoradiation and MRI-guided brachytherapy.
Gynecol Oncol. 2024;190:153-159. PubMedAbstract available
WAGAR MK, Patel UJ, Bharucha K, Heisler CA, et al Postoperative urinary retention by void trial methodology following radical
hysterectomy for cervical cancer.
Gynecol Oncol. 2024;190:90-95. PubMedAbstract available
FROEDING LP, Jensen PT Commentary on "Simple versus radical hysterectomy in women with low-risk cervical
cancer" by Plante M. et al. published in The New England Journal of Medicine.
Gynecol Oncol. 2024;189:137. PubMed
ADOLPH L, Mann A, Liu XQ, Roberts L, et al Follow-up of women with cervical adenocarcinoma in situ treated by conization: A
single centre clinical experience.
Gynecol Oncol. 2024;187:74-79. PubMedAbstract available
July 2024
DA COSTA AABA, Souza RP, Pandolfi NC, de Souza Castro F, et al Should we consider progression-free survival benefits enough for drug approvals
in locally advanced cervical cancer?
Gynecol Oncol. 2024;189:109-110. PubMed
BERGSTEIN A, Huang Y, Hershman DL, Xu X, et al Impact of medicaid expansion on cervical cancer screening: A state-specific
difference in difference analysis.
Gynecol Oncol. 2024;189:49-55. PubMedAbstract available
June 2024
KA K, Cordoba A, Cagetti LV, Schiappa R, et al Preoperative brachytherapy of early-stage cervical cancer: A multicenter study by
the SFRO brachytherapy group.
Gynecol Oncol. 2024;188:90-96. PubMedAbstract available
KOCIAN R, Kohler C, Bajsova S, Jarkovsky J, et al Sentinel lymph node pathological ultrastaging: Final outcome of the Sentix
prospective international study in patients with early-stage cervical cancer.
Gynecol Oncol. 2024;188:83-89. PubMedAbstract available
WALKER CA, Edwards C, McIntire D, Makepeace L, et al Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent
cervical cancer.
Gynecol Oncol. 2024;188:22-26. PubMedAbstract available
O'CONNOR RM, Huang DS, Rimel BJ, Kim KH, et al Unmet financial needs among patients crowdfunding to support gynecologic cancer
care.
Gynecol Oncol. 2024;186:199-203. PubMedAbstract available
CHALIF J, Kistenfeger Q, Fulton J, Morton M, et al Diagnosis and management of gastric-type endocervical adenocarcinoma: A case
report and review of the literature.
Gynecol Oncol. 2024;185:165-172. PubMedAbstract available
May 2024
PERSSON J, Luhrs O, Geppert B, Ekdahl L, et al A prospective study evaluating an optimized sentinel node algorithm in early
stage cervical cancer: The PROSACC-study.
Gynecol Oncol. 2024;187:178-183. PubMedAbstract available
HUNSBERGER KS, Treiman S, Monk BJ, Tewari KS, et al A systematic review of stage IVA cervical cancer treatment: Challenges in the
management of an understudied group.
Gynecol Oncol. 2024;187:120-127. PubMedAbstract available
CHIBA Y, Kojima Y, Yazaki S, Yoshida H, et al Trop-2 expression and the tumor immune microenvironment in cervical cancer.
Gynecol Oncol. 2024;187:51-57. PubMedAbstract available
MACCHIA G, Cilla S, Pezzulla D, Campitelli M, et al Efficacy of stereotactic body radiotherapy and response prediction using
artificial intelligence in oligometastatic gynaecologic cancer.
Gynecol Oncol. 2024;184:16-23. PubMedAbstract available
April 2024
VESZTERGOM D, Teglas G, Bahrehmand K, Torok A, et al Reducing radicality in fertility-sparing surgery is associated with improved in
vitro fertilization outcome in early-stage cervical cancer: A national
retrospective study.
Gynecol Oncol. 2024;186:35-41. PubMedAbstract available
March 2024
ROSS DH, Gomez K, Harmon G, Mysz ML, et al Evaluating outcomes and toxicities for a newly implemented MRI-based
brachytherapy program for cervical cancer.
Gynecol Oncol. 2024;183:33-38. PubMedAbstract available
GASS P, Thiel FC, Haberle L, Ackermann S, et al Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III
study to compare the effects of paclitaxel and topotecan with those of cisplatin
and topotecan in the treatment of patients with recurrent and persistent cervical
cancer.
Gynecol Oncol. 2024;183:25-32. PubMedAbstract available
February 2024
NICA A, Benseler A, Parbhakar A, Fortin LT, et al Robotic versus vaginal radical trachelectomy for reproductive-aged patients with
early-stage cervical carcinoma: A multi-center cohort study.
Gynecol Oncol. 2024;185:95-100. PubMedAbstract available
ROOF KA, Wichmann HK, Carlton LJ, Nguyen ML, et al Factors associated with loss to follow up after abnormal cervical cancer
screening in pregnancy.
Gynecol Oncol. 2024;185:46-50. PubMedAbstract available
KUCERA CW, Chappell NP, Tian C, Richardson MT, et al Survival disparities in non-Hispanic Black and White cervical cancer patients
vary by histology and are largely explained by modifiable factors.
Gynecol Oncol. 2024;184:224-235. PubMedAbstract available
DINICU AI, Dioun S, Wang Y, Huang Y, et al Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated
with disparities in guideline-concordant care.
Gynecol Oncol. 2024;184:214-223. PubMedAbstract available
PELTECU G Eugen Bogdan Aburel, a pioneer of fertility sparing surgery.
Gynecol Oncol. 2024;181:40-45. PubMedAbstract available
January 2024
DORISMOND VG, Saraiya M, Gopalani SV, Soman A, et al Variation in cervical cancer screening test utilization and results in a United
States-based program.
Gynecol Oncol. 2024;184:96-102. PubMedAbstract available
BEFANO B, Wentzensen N, Lorey T, Poitras N, et al Calendar-period trends in cervical precancer and cancer diagnoses since the
introduction of human papillomavirus and cytology co-testing into routine
cervical cancer screening at Kaiser Permanente Northern California.
Gynecol Oncol. 2024;184:89-95. PubMedAbstract available
MANNING-GEIST B, Grace MA, Sonoda Y Trachelectomy and fertility-sparing procedures for early-stage cervical cancer: A
state of the science review.
Gynecol Oncol. 2024;181:179-182. PubMed
LEE SS, Gold HT, Kwon SC, Pothuri B, et al Guideline concordant care for patients with locally advanced cervical cancer by
disaggregated Asian American and Native Hawaiian/Pacific Islander groups: A
National Cancer Database Analysis.
Gynecol Oncol. 2024;182:132-140. PubMedAbstract available
CHOI KH, Lee HC, Kim YS, Park W, et al Diagnostic assessments and treatment results of well-differentiated gastric-type
adenocarcinoma of the uterine cervix (Adenoma malignum): A multicenter
retrospective analysis of KROG 22-03 study.
Gynecol Oncol. 2024;182:45-50. PubMedAbstract available
FRIEDMAN CF, D'Souza A, Bello Roufai D, Tinker AV, et al Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results
from the phase 2 SUMMIT basket trial.
Gynecol Oncol. 2024;181:162-169. PubMedAbstract available
December 2023
TJIOE KC, Miranda-Galvis M, Johnson MS, Agrawal G, et al The interaction between social determinants of health and cervical cancer
survival: A systematic review.
Gynecol Oncol. 2023;181:141-154. PubMedAbstract available
HALLE MK, Bozickovic O, Forsse D, Wagner-Larsen KS, et al Clinicopathological and radiological stratification within FIGO 2018 stages
improves risk-prediction in cervical cancer.
Gynecol Oncol. 2023;181:110-117. PubMedAbstract available
RIVES TA, Orellana TJ, Mumford BS, Sukumvanich P, et al The role of obesity in treatment planning for early-stage cervical cancer.
Gynecol Oncol. 2023;181:60-67. PubMedAbstract available
URBUTE A, Frederiksen K, Thomsen LT, Kesmodel US, et al Overweight and obesity as risk factors for cervical cancer and detection of
precancers among screened women: A nationwide, population-based cohort study.
Gynecol Oncol. 2023;181:20-27. PubMedAbstract available
VAHTERISTO M, Leinonen MK, Sarkeala T, Anttila A, et al Similar effectiveness with primary HPV and cytology screening - Long-term
follow-up of randomized cervical cancer screening trial.
Gynecol Oncol. 2023;180:146-151. PubMedAbstract available
HSIEH K, Bloom JR, Dickstein DR, Hsieh C, et al Dose and fractionation regimen for brachytherapy boost in cervical cancer in the
US.
Gynecol Oncol. 2023;180:55-62. PubMedAbstract available
RAI R, Lightfoot S, Benbrook DM Manipulation of metabolic responses enhances SHetA2 efficacy without toxicity in
cervical cancer cell lines and xenografts.
Gynecol Oncol. 2023;180:44-54. PubMedAbstract available
SAMMOURI J, Venkatesan AM, Lin LL, Jhingran A, et al Management and long-term clinical outcomes of patients with stage IVA cervical
cancer with bladder involvement.
Gynecol Oncol. 2023;180:24-34. PubMedAbstract available
LONG E, Macdonald MC, Parker VL, Lyon R, et al Factors associated with failed 'test of cure' in the NHS Cervical Screening
Programme: A retrospective cohort study.
Gynecol Oncol. 2023;179:158-163. PubMedAbstract available
November 2023
NASIOUDIS D, Gysler S, Latif N, Cory L, et al Molecular landscape of ERBB2/HER2 gene amplification among patients with
gynecologic malignancies; clinical implications and future directions.
Gynecol Oncol. 2023;180:1-5. PubMedAbstract available
HERMANN CE, Patel JM, Boyd L, Growdon WB, et al Let's chat about cervical cancer: Assessing the accuracy of ChatGPT responses to
cervical cancer questions.
Gynecol Oncol. 2023;179:164-168. PubMedAbstract available
GIRDA E, Randall LM, Chino F, Monk BJ, et al Cervical cancer treatment update: A Society of Gynecologic Oncology clinical
practice statement.
Gynecol Oncol. 2023;179:115-122. PubMedAbstract available
KUMAR R, Sherwani Z, Lopez M, Vergalasova I, et al Disparities in brachytherapy utilization in cervical cancer in the United States:
A comprehensive literature review.
Gynecol Oncol. 2023;179:79-84. PubMedAbstract available
WICKENHEISSER NE, Dillon M, Broadwater G, Zacherl K, et al Radical hysterectomy case volume and cervical cancer treatment in the era of
COVID-19: A multi-site analysis of National Cancer Institute-designated
Comprehensive Cancer Centers.
Gynecol Oncol. 2023;179:70-78. PubMedAbstract available
SUMMEY R, Benoit M, Williams-Brown MY Survival differences by race and surgical approach in early-stage operable
cervical Cancer.
Gynecol Oncol. 2023;179:63-69. PubMedAbstract available
CHEN F, Zhang GN, Lei W, Zhou SG, et al Effectiveness and safety of REBACIN as a non-invasive intervention for persistent
high-risk human papillomavirus infection: A real-world prospective multicenter
cohort study.
Gynecol Oncol. 2023;178:8-13. PubMedAbstract available
October 2023
BAETEN IGT, Hoogendam JP, Schreuder HWR, Jurgenliemk-Schulz IM, et al Introducing a novice surgeon to an experienced robotic gynaecological oncology
team: An observational cohort study on the impact of a structured curriculum on
outcomes of cervical cancer surgery.
Gynecol Oncol. 2023;178:153-160. PubMedAbstract available
CHAPMAN GC, Smrz SA, Gordon JC, Lynam SK, et al Gynecologic cancer care in the first year of the COVID-19 pandemic.
Gynecol Oncol. 2023;178:138-144. PubMedAbstract available
September 2023
AGUSTI N, Viveros-Carreno D, Mora-Soto N, Ramirez PT, et al Diagnostic accuracy of sentinel lymph node frozen section analysis in patients
with early-stage cervical cancer: A systematic review and meta-analysis.
Gynecol Oncol. 2023;177:157-164. PubMedAbstract available
LEE HC, Jeong JW, Lee JH, Kim SH, et al High-dose (60 Gy) intensity-modulated radiotherapy with concurrent weekly
cisplatin followed by intracavitary radiation in locally advanced cervical
cancer: A phase II prospective clinical trial.
Gynecol Oncol. 2023;177:142-149. PubMedAbstract available
PRAISS AM, Allison D, Tessier-Cloutier B, Flynn J, et al Extensive versus focal lymphovascular invasion in squamous cell carcinoma of the
cervix: A comprehensive international, multicenter, retrospective
clinicopathologic study.
Gynecol Oncol. 2023;176:147-154. PubMedAbstract available
August 2023
KOROMPELIS P, Rundle S, Cassar V, Ratnavelu N, et al "Conservative surgical approaches for small volume FIGO stage IB1 cervical
cancer. Updated survival and obstetric outcomes of an expanded cohort".
Gynecol Oncol. 2023;176:155-161. PubMedAbstract available
July 2023
KONG TW, Kim J, Son JH, Lee AJ, et al Is minimally invasive radical surgery safe for patients with cervical cancer
=2 cm in size? (MISAFE): Gynecologic Oncology Research Investigators coLLborAtion
study (GORILLA-1003).
Gynecol Oncol. 2023;176:122-129. PubMedAbstract available
EIDE AJ, Halle MK, Lura N, Fasmer KE, et al Visceral fat percentage for prediction of outcome in uterine cervical cancer.
Gynecol Oncol. 2023;176:62-68. PubMedAbstract available
KAHVECIOGLU A, Gurlek E, Yedekci FY, Sari SY, et al Simultaneous integrated or sequential boost to clinically involved lymph nodes in
patients with locally advanced cervical cancer treated with definitive
chemoradiotherapy.
Gynecol Oncol. 2023;176:10-15. PubMedAbstract available
June 2023
KONSKI A, Deshmukh S, Klopp AH, Yeung AR, et al Quality-adjusted survival in women with gynecologic malignancies receiving IMRT
after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203.
Gynecol Oncol. 2023;175:176-181. PubMedAbstract available
MAH SJ, Carter Ramirez DM, Eiriksson LR, Schnarr K, et al Palliative care utilization across health sectors for patients with gynecologic
malignancies in Ontario, Canada from 2006 to 2018.
Gynecol Oncol. 2023;175:169-175. PubMedAbstract available
LI J, Xue X, Zhang Y, Ding F, et al The differences in immune features and genomic profiling between squamous cell
carcinoma and adenocarcinoma - A multi-center study in Chinese patients with
uterine cervical cancer.
Gynecol Oncol. 2023;175:133-141. PubMedAbstract available
MORTON M, Haight PJ, Khadraoui W, Backes F, et al "More than a song and dance": Exploration of patient perspectives and educational
quality of gynecologic cancer content on TikTok.
Gynecol Oncol. 2023;175:81-87. PubMedAbstract available
KULKARNI A, Chen L, Gockley A, Khoury-Collado F, et al Patterns of cervical cancer screening follow-up in the era of prolonged screening
intervals.
Gynecol Oncol. 2023;175:53-59. PubMedAbstract available
LEVINE MD, Barrington DA, Meade CE, Lammers SM, et al Glassy cell carcinoma of the cervix: Findings from a combined National Cancer
Database analysis and single institution review of treatment patterns and
outcomes.
Gynecol Oncol. 2023;173:15-21. PubMedAbstract available
May 2023
SCHIFFMAN M, Mirabello L, Egemen D, Befano B, et al The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells
(AGC) indicates a greatly elevated risk of in situ and invasive cervical
adenocarcinoma.
Gynecol Oncol. 2023;174:253-261. PubMedAbstract available
KIM NR, Kim SI, Suh DH, Kim HS, et al Survival outcomes of laparoscopic versus open radical hysterectomy in early
cervical cancer with incidentally identified high-risk factors.
Gynecol Oncol. 2023;174:224-230. PubMedAbstract available
HAN L, Chen Y, Zheng A, Chen H, et al Effect of preoperative cervical conization before hysterectomy on survival and
recurrence of patients with cervical cancer: A systematic review and
meta-analysis.
Gynecol Oncol. 2023;174:167-174. PubMedAbstract available
VERGOTE I, Van Nieuwenhuysen E, Casado A, Laenen A, et al Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or
without nintedanib in first-line recurrent or advanced cervical cancer.
Gynecol Oncol. 2023;174:80-88. PubMedAbstract available
ROBOVA H, Rob L, Halaska MJ, Drozenova J, et al Twenty years of experience with less radical fertility-sparing surgery in
early-stage cervical cancer: Pregnancy outcomes.
Gynecol Oncol. 2023;174:76-79. PubMedAbstract available
DI DONATO V, Bogani G, Casarin J, Ghezzi F, et al Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy
for "low-risk" early-stage cervical cancer: A propensity-score based analysis.
Gynecol Oncol. 2023;174:49-54. PubMedAbstract available
STOLER MH, Parvu V, Yanson K, Andrews J, et al Risk stratification of HPV-positive results using extended genotyping and
cytology: Data from the baseline phase of the Onclarity trial.
Gynecol Oncol. 2023;174:68-75. PubMedAbstract available
PIEDIMONTE S, Helpman L, Pond G, Nelson G, et al Surgical margin status in relation to surgical approach in the management of
early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) study.
Gynecol Oncol. 2023;174:21-27. PubMedAbstract available
FUREY KB, Anderson ZS, Kuznicki ML, Klar M, et al Increasing trends of cervical conization with lymph node evaluation for
fertility-sparing surgery in early cervical cancer.
Gynecol Oncol. 2023;173:122-129. PubMedAbstract available
April 2023
KIM SI, Nam SH, Hwangbo S, Kim Y, et al Conization before radical hysterectomy in patients with early-stage cervical
cancer: A Korean multicenter study (COBRA-R).
Gynecol Oncol. 2023;173:88-97. PubMedAbstract available
GARCIA-SAYRE J, Lin YG, Matuso K, Tsao-Wei DD, et al Two staged phase II clinical trial of Eribulin monotherapy in advanced or
recurrent cervical cancer.
Gynecol Oncol. 2023;173:49-57. PubMedAbstract available
CIBULA D The group with the most heterogenous treatment among patients with cervical
cancer.
Gynecol Oncol. 2023 Apr 17:S0090-8258(23)00169. PubMed
March 2023
TEWARI KS, Sill MW, Birrer MJ, Penson RT, et al Final survival analysis of topotecan and paclitaxel for first-line treatment of
advanced cervical Cancer: A NRG oncology randomized study.
Gynecol Oncol. 2023;171:141-150. PubMedAbstract available
MOOLENAAR LR, van Rangelrooij LE, van Poelgeest MIE, van Beurden M, et al Clinical outcomes of pelvic exenteration for gynecologic malignancies.
Gynecol Oncol. 2023;171:114-120. PubMedAbstract available
STOLER MH, Wright TC Jr, Parvu V, Yanson K, et al Detection of high-grade cervical neoplasia using extended genotyping: Performance
data from the longitudinal phase of the Onclarity trial.
Gynecol Oncol. 2023;170:143-152. PubMedAbstract available
February 2023
BENBROOK DM, Deng W, Gold MA, Rai R, et al Association of Sialyl Tn antigen with cervical cancer lymph node status: An NRG
oncology/GOG study.
Gynecol Oncol. 2023;171:67-75. PubMedAbstract available
KIM C, Salvo G, Ishikawa M, Chen TC, et al The role of postoperative radiation after radical hysterectomy for women with
early-stage neuroendocrine carcinoma of the cervix: A meta-analysis.
Gynecol Oncol. 2023;170:328-332. PubMedAbstract available
KAUR A, Wang S, Kumar A Impact of racial disparities on potential years of life lost due to gynecologic
cancer in the United States: Trends from 1975 to 2017 based on SEER database.
Gynecol Oncol. 2023;170:266-272. PubMedAbstract available
HOLLOWAY SB, Mercadel AJ, Miller DS, Lea JS, et al Isolated para-aortic nodal recurrence after treatment of early stage cervical
carcinoma.
Gynecol Oncol. 2023;170:248-253. PubMedAbstract available
January 2023
LU L, Liu T, Wang S, Li J, et al Joint detection of multiple HPV-testing technologies and evaluation of
clinicopathological characteristics discriminate between HPV-independent and
low-copy HPV-associated cervical squamous cell carcinoma (CSCC) -an analysis of
3869 cases.
Gynecol Oncol. 2023;170:59-69. PubMedAbstract available
September 2022
HOLM J, Gerke O, Vilstrup MH, Spasojevic D, et al Improved stratification of stage-specific survival for cervical uterine cancer by
integrating FDG-PET/CT and MRI for lymph node staging in 2018 FIGO
classification.
Gynecol Oncol. 2022 Sep 28. pii: S0090-8258(22)01841. PubMedAbstract available